Latest Non Dilutive Funding News

Butn Limited has locked in a $10 million corporate credit facility with Mighty Partners, providing non-dilutive capital to support its expanding receivables book and operational growth.

Sun Silver Limited has verified significant antimony mineralisation at its Maverick Springs Project in Nevada, with historical drill core re-assays revealing broad intercepts and visual stibnite presence. The company is advancing a strategic engagement with the US Department of Defence to position the project as a critical domestic mineral source.

Argenica Therapeutics has won up to $1.5 million in non-dilutive government funding to support its late-stage clinical trial of ARG-007, a promising treatment for acute ischaemic stroke.

South Harz Potash Limited has launched a two-tranche equity raising to secure up to A$3.11 million, aiming to advance its dual-asset strategy and strengthen its position in the European potash market.

Everest Metals has been accepted into the US Defence Industrial Base Consortium, unlocking strategic collaboration and funding opportunities for its Mt Edon Rubidium Project in Western Australia. This milestone advances Australia’s first commercial rubidium production, addressing critical global supply shortages.

Recce Pharmaceuticals has locked in a non-dilutive A$30 million debt facility with Avenue Capital Group, extending its cash runway to support pivotal Phase 3 trials and commercialisation of its synthetic anti-infective R327G.

Hazer Group has raised A$8 million through a share placement and launched a A$2 million Share Purchase Plan to accelerate its clean hydrogen and graphite technology commercialisation.

EMVision Medical Devices has secured a $5 million non-dilutive government grant to accelerate global commercialisation of its innovative First Responder portable brain scanner, aimed at revolutionising pre-hospital stroke and brain injury care.

Cokal Limited has secured US$15 million in strategic debt funding to ramp up metallurgical coal production at its BBM mine, while terminating all agreements with Cratus due to non-performance.

Resolution Minerals Limited has secured the Horse Heaven Project in Idaho, adjacent to the major Stibnite Gold Project, aiming to address critical US antimony supply shortages with a planned 2025 drilling campaign.

Chimeric Therapeutics has secured a $2.5 million advance against its FY25 R&D tax incentive, bolstering funding for its clinical trial pipeline and operational needs. This move complements recent capital raises and underscores the company’s strategic financial management amid its oncology-focused cell therapy development.

Kincora Copper Limited has unlocked over A$110 million in partner funding through six strategic deals, advancing extensive drilling programs across its copper-gold projects in New South Wales and Mongolia. The company’s project generator model is driving exploration momentum with key partners including AngloGold Ashanti and innovative collaborators like Earth AI and Fleet Space.